Health Trials

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Clinical Study of HX111 in Patients With Advanced Solid Tumor and Lymphoma

The study will consist of a Phase I dose-escalation and Phase IIa dose-expansion component. Phase I dose-escalation phase will establish the maximum tolerated dose (MTD) and/or recommended Phase 2 dose (RP2D),and evaluate the preliminary antitumor activity of HX111.

Participants needed: 70
Trial details
Phase: Phase 1, Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: Hanx Biopharmaceuticals (Wuhan) Co., Ltd.Updated: Jan 13, 2026
Eligibility criteria

1. Able to understand and voluntarily sign the Informed Consent Form (ICF); 2. M... [+8]

1. Prior malignancy active within the previous 2 years except for the tumor for... [+3]

Read more
Status: Recruiting

HX044,FIH Study in Patients with Advanced Solid Tumor Malignancies

The study will consist of a dose-escalation and dose-expansion component to establish the maximum tolerated dose (MTD) and/or recommended Phase 2 dose (RP2D), and to evaluate the preliminary antitumor activity of HX044. HX044 is an investigational drug that has not yet been approved by the Food and Drug Administration (FDA) or any other regulatory authorities for commercial purposes. This is the first study in which HX044 will be given to humans. The study drug has been tested in animals and was found to be well-tolerated with minimal side effects.

Participants needed: 100
Trial details
Phase: Phase 1, Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Hanx Biopharmaceuticals (Wuhan) Co., Ltd.Updated: Jan 14, 2025Locations: 3
Eligibility criteria

Subjects must voluntarily agree to participate by providing written informed con... [+10]

Prior malignancy active within the previous 5 years except for the tumor for whi... [+13]

Read more